Merseyside & Cheshire Cancer Network Dashboard
Merseyside & Cheshire Cancer Network Dashboard Merseyside & Cheshire Cancer Network Dashboard
Background The National Awareness and Early Detection Initiative-NAEDI- was announced in the Cancer Reform Strategy (CRS) and is being led by Professor Mike Richards, National Cancer Director and Harpel Kumar the Chief Executive of Cancer Research UK. Cancer Networks are well placed to provide leadership for prevention and early diagnosis. Cancer Networks and PCTs are expected to undertake a baseline assessment that will inform Network and PCT Strategic Commissioning Plans to ensure effective progress in this area based on local needs. A Cancer Dashboard The cancer network have developed performance measures that include baseline measures but also add further quality to information that is appropriate for PCTs and GP practices and we want to embed these into a more robust cancer dashboard using and testing measures. We see this as a way of assessing current baselines within PCTs and also practices but will also enable us to analyse performance regularly. The cancer dashboard will be outcome driven; each PCT will be asked to complete a template with the Early Detection and Awareness Strategy lead team. We will agree milestones with PCTs and assist them in supporting the gathering of evidence for the individual measures, including measures by practice. We envisage that action plans will be developed and adopted by PCT boards as appropriate and recommendations will be made to commissioners, these recommendations will be more likely to be considered as they will be evidence based. A key element of the cancer dashboard will be the development of a database that PCTs and practices can access to review performance and to create reports. The cancer dashboard will: Collate primary care equity audits for urgent referrals in the PCT by practice- this will include, review of referring patterns linked to deprivation, number of referrals, cancer yield. This is different than the primary care audits. Capture data within templates for survival, mortality, incidence, screening and staging data and will identify key trends and variations. Provide PCT reporting in a template that will demonstrate compliance with national and local baseline assessments identified within the Cancer Reform Strategy. Provide information about screening performance at GP practice and PCT level, templates for GP practices will be made available. Capture action plans to enable Commissioners to make decisions on services. Test other performance measures around commissioning such as length of stay analysis and other commissioning priorities. We believe that the cancer dashboard will enhance the PCTs ability to demonstrate their progress on world class commissioning (WCC) and quality, innovation, productivity and prevention (QUIPP) Dr Daniel Seddon- Early detection and prevention lead Paul Mackenzie- Health Inequalities Manager Version 2 Cancer Dashboard MCCN 2010 2
Baseline key metrics and indicators for the Cancer Dashboard. No Performance category Network PCT Practice Trust 1. Proportion of diagnosed cancers reaching a 90% registration status (including staging) with √ √ √ NWCIS after 90 days 2. TWW activity including did not attend (DNA) and cancellation rates √ √ √ √ 3. Total number of Urgent 2 week wait referrals by tumour site √ √ √ √ 4. Urgent 2 week wait cancer referral yield rate by tumour site (Yield = No of Diagnosis Cancers/ √ √ √ Number of Urgent 2 week wait referrals 5. Number of Urgent 2 week wait cancer referrals by tumour site with a cancer diagnosis √ 6. Coverage rates for national bowel cancer screening programme √ √ 7. % variation from national coverage rates for bowel cancer screening programme √ √ 8. Number of cancers detected as a result of the bowel cancer screening programme √ √ 9. % Never screened for bowel cancer √ √ 10. Coverage rates for national cervical screening programme √ √ 11. % variation from national coverage rates for the cervical screening programme √ √ 12. Number of cancers detected as a result of the cervical screening programme √ √ 13. % Never screened for cervical cancer √ √ 14. % patients receiving cervical screening results within 2 weeks following screening √ 15. Lab data 16. Coverage rates for national breast screening programme √ √ 17. % variation from national coverage rates for the breast screening programme √ √ 18. Number of cancers detected as a result of the breast screening programme √ √ 19. % Never screened for breast cancer √ √ 20. European Age Standardised Cancer Incidence rates for all cancers compared to the national √ √ average and best in Europe (if appropriate) 21. European Age Standardised Cancer Mortality rates for all cancers compared to the national √ √ average and best in Europe (if appropriate) 22. % variation in 1 year relative survival rates for all cancers compared to the national average and √ best in Europe (if appropriate) 23. % variation in 5 year relative survival rates for all cancers compared to the national average and √ best in Europe (if appropriate) 24. Number of emergency admissions resulting in the first definitive cancer diagnosis √ √ √
- Page 1: Merseyside & Cheshire Cancer Networ
- Page 5 and 6: Public awareness 1b Has the PCT eng
- Page 7 and 8: Operational leadership 2a Does the
- Page 9 and 10: Breast cancer screening coverage 2f
- Page 11 and 12: 3. Delays in presentation/ Referral
- Page 13 and 14: 4. Staging The information for the
- Page 15 and 16: 4f Level 1 Level 2 Level 3 Level 4
- Page 17 and 18: 4l Level 1 Level 2 Level 3 Level 4
- Page 19 and 20: How will the PCT reduce cancer mort
- Page 21 and 22: 8. Local Plans: Findings from local
- Page 23: Cancer Performance summary table fo
Baseline key metrics and indicators for the <strong>Cancer</strong> <strong>Dashboard</strong>.<br />
No Performance category <strong>Network</strong> PCT Practice Trust<br />
1. Proportion of diagnosed cancers reaching a 90% registration status (including staging) with<br />
√ √ √<br />
NWCIS after 90 days<br />
2. TWW activity including did not attend (DNA) and cancellation rates √ √ √ √<br />
3. Total number of Urgent 2 week wait referrals by tumour site √ √ √ √<br />
4. Urgent 2 week wait cancer referral yield rate by tumour site (Yield = No of Diagnosis <strong>Cancer</strong>s/<br />
√ √ √<br />
Number of Urgent 2 week wait referrals<br />
5. Number of Urgent 2 week wait cancer referrals by tumour site with a cancer diagnosis √<br />
6. Coverage rates for national bowel cancer screening programme √ √<br />
7. % variation from national coverage rates for bowel cancer screening programme √ √<br />
8. Number of cancers detected as a result of the bowel cancer screening programme √ √<br />
9. % Never screened for bowel cancer √ √<br />
10. Coverage rates for national cervical screening programme √ √<br />
11. % variation from national coverage rates for the cervical screening programme √ √<br />
12. Number of cancers detected as a result of the cervical screening programme √ √<br />
13. % Never screened for cervical cancer √ √<br />
14. % patients receiving cervical screening results within 2 weeks following screening √<br />
15. Lab data<br />
16. Coverage rates for national breast screening programme √ √<br />
17. % variation from national coverage rates for the breast screening programme √ √<br />
18. Number of cancers detected as a result of the breast screening programme √ √<br />
19. % Never screened for breast cancer √ √<br />
20. European Age Standardised <strong>Cancer</strong> Incidence rates for all cancers compared to the national<br />
√<br />
√<br />
average and best in Europe (if appropriate)<br />
21. European Age Standardised <strong>Cancer</strong> Mortality rates for all cancers compared to the national<br />
√<br />
√<br />
average and best in Europe (if appropriate)<br />
22. % variation in 1 year relative survival rates for all cancers compared to the national average and √<br />
best in Europe (if appropriate)<br />
23. % variation in 5 year relative survival rates for all cancers compared to the national average and √<br />
best in Europe (if appropriate)<br />
24. Number of emergency admissions resulting in the first definitive cancer diagnosis √ √ √
Change language